20/20 Biolabs annual meeting: directors elected, auditor ratified, charter amendment fails, adjourned to Sept 16

20/20 Biolabs, Inc.

Six directors elected: Jonathan Cohen, John G. Compton, Richard M. Cohen, Prasanth Reddy, John W. Rollins, Michael A. Ross; each received >2.6M votes for.
Ratified dbbmckennon as independent auditor for FY2026: 4,105,584 for, 132,421 against, 18,832 abstentions.
Approved 2026 Equity Incentive Plan: 2,183,335 for, 573,931 against, 1,433,721 broker non-votes.
Proposal 3 (Charter Amendment) failed to get sufficient votes; meeting adjourned to Sept 16, 2026 at 10:00 a.m. ET to solicit more proxies.
Quorum: 4,256,837 shares represented out of 12,251,198 outstanding.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.